Roic AI
Search
/
  1. Sweden Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers—Specialty & Generic
N

Newbury Pharmaceuticals AB (publ)

NEWBURY SS

Newbury Pharmaceuticals AB (publ)SESweden Composite

3.67

SEK
+0.01
(+0.27%)

Upgrade to Unlock Non-US CompaniesTo view real-time data and analysis of companies outside of the United States, upgrade your account to our premium subscription. 

Upgrade
Newbury Pharmaceuticals AB (publ)
NEWBURY:SS
(Sweden Composite)

Recent

price

3.67

P/E

ratio

-3.66

div

yld

- -

ROIC.AI

Legends:
Stock price
- -
Beta (1.0 Market)
% total return 11/28
Stock
S&P500
YTD
-57.36
- -
3Y
- -
- -
5Y
- -
- -
Business
Newbury Pharmaceuticals AB (publ), a pharmaceutical company, produces and commercializes in-licensed specialty prescription drugs in Sweden, Denmark, Norway, and other Scandinavian countries. It offers oncology drugs, such as Lenalidomide, Sunitinib, Pazopanib, Lapatinib, Bosutinib, Lenvatinib, Enzalutamide, Nilotinib, Pomalidomide, Palbociclib, and Nintedanib; drugs for rare diseases, including Icatibant, Macitentan, Pirfenidone, and Teduglutide; neurology drugs, which include dimetylfumarat, lorazepam ER, teriflunomide, and fampridine; and drugs for various other therapeutic areas comprising Solifenacin + Tamsulosin, Liraglutide, Desmopressin ODT, Gabapentin ER, Rivaroxaban, Ticagrelor, Tofacitinib, and Varenicline. The company was incorporated in 2020 and is based in Lund, Sweden.